News

iHuman Inc. Unveils 2024 Financial Results and Future Outlook

iHuman Inc. Unveils 2024 Financial Results and Future Outlook

iHuman Inc. Announces Fourth Quarter and Fiscal Year Financial Results

iHuman Inc. (NYSE: IH), a frontrunner in tech-powered intellectual development products, recently disclosed its unaudited financial results for the fourth quarter and the entire fiscal year 2024. The company continues to demonstrate resilience amid changing market conditions, ensuring its dedication to providing innovative solutions for childhood education.

Fourth Quarter 2024 Highlights

The company reported revenues of RMB232.7 million (approximately US$31.9 million), marking a decline from RMB250.4 million recorded during the prior year's fourth quarter. This dip was attributed mainly to a decrease in birth rates in the region and a shift towards more cautious consumer spending.

Gross Profit Analysis

In this quarter, gross profit stood at RMB156.4 million (US$21.4 million), compared to RMB178.2 million in the same period last year. The gross margin saw a slight contraction, settling at 67.2%, down from 71.2% due to efforts in diversifying and enhancing product offerings.

Operating and Net Income

Operating income for the fourth quarter was recorded at RMB14.9 million (US$2.0 million), a decrease from RMB21.9 million a year earlier. On a positive note, net income reached RMB26.5 million (US$3.6 million), although it declined from RMB33.3 million in the previous year. The monthly active user (MAU) count increased to 25.78 million, reflecting growth in engagement with iHuman's products.

Fiscal Year 2024 Overview

For the full fiscal year, iHuman recorded revenues of RMB922.2 million (US$126.3 million), down from RMB1,018.1 million in 2023. The company's gross profit hit RMB640.2 million (US$87.7 million), reflecting a significant adjustment from the previous fiscal year's RMB721.3 million.

Annual Operational Metrics

Operating income saw a substantial drop to RMB71.9 million (US$9.9 million) from RMB159.9 million the year prior. However, net income was reported at RMB98.6 million (US$13.5 million), also down from RMB180.9 million in 2023. Despite these reductions, the growth in average total MAUs to 26.47 million—an increase from 23.04 million—indicates a successful user acquisition strategy.

Innovation and Market Trends

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, emphasized the company’s commitment to innovation, particularly through artificial intelligence. The establishment of their AI Lab in 2018 has led to the integration of AI-generated content into their educational tools. The advent of products like iHuman Smart Coder showcases their innovative approach, offering personalized learning experiences in coding through intuitive user interactions.

Continuing to Innovate

As iHuman navigates the landscape of education technology, its strategy focuses on merging AI capabilities with traditional learning methods to enhance user engagement. The company is proactively aligning its offerings with market trends, ensuring their products remain relevant and effective in a constantly evolving market.

Special Cash Dividend Announced

The Board of Directors has approved a special cash dividend of US$0.02 per ordinary share, reaffirming the company’s commitment to shareholder value. This continuous dividend payment highlights the strength and resilience of iHuman’s business model even in challenging economic conditions.

Animation Studio Developments

Furthermore, the company’s animation studio, Kunpeng, has made strides in commercializing their animation properties, notably the successful Rainbow Crew series, which has boosted their brand presence and user engagement. Launching merchandise and expanding into global platforms such as YouTube showcases iHuman's innovative marketing strategies as they look toward international growth.

Future Growth and Strategies

As iHuman sets its sights on 2025, continued improvements in product innovation and market adaptation remain essential. The integration of AI technologies alongside creative content development will guide their mission forward, ultimately enhancing user experiences globally. With persistent commitment to innovation, iHuman Inc. is poised to thrive and expand within the competitive landscape of childhood education technology.

Frequently Asked Questions

1. What were iHuman's revenues for the fourth quarter of 2024?

iHuman reported revenues of RMB232.7 million (US$31.9 million) for the fourth quarter of 2024.

2. How did iHuman's gross profit change in 2024?

In 2024, iHuman's gross profit was RMB640.2 million (US$87.7 million), down from RMB721.3 million the previous year.

3. What innovative products has iHuman developed recently?

iHuman recently developed the iHuman Smart Coder, providing personalized coding education through AI integration.

4. What dividend has iHuman announced?

The Board of Directors has approved a special cash dividend of US$0.02 per ordinary share.

5. What is the future outlook for iHuman Inc.?

iHuman aims to further strengthen its product innovation and market relevance through AI advancements while focusing on user engagement and international expansion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 392

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 253

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 204

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 200

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading